Allyl 2,7-diazaspiro[3.5]nonane-2-carboxylate hydrochloride

Catalog No.: 
ACWNML252
CAS No.: 
2007921-06-2
Molecular Formula: 
C11H19ClN2O2
Molecular Weight: 
246.74
Allyl 2,7-diazaspiro[3.5]nonane-2-carboxylate hydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg97%$795.00InquiryInquiry
1g97%$1321.00InquiryInquiry
5g97%$4624.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameAllyl 2,7-diazaspiro[3.5]nonane-2-carboxylate hydrochloride
IUPAC Nameallyl 2,7-diazaspiro[3.5]nonane-2-carboxylate hydrochloride
Molecular FormulaC11H19ClN2O2
Molecular Weight246.74
SMILESO=C(N1CC2(CCNCC2)C1)OCC=C.[H]Cl
InChI KeyUJDUWYHDTBCMRQ-UHFFFAOYSA-N
SynonymAllyl 2,7-Diazaspiro[3.5]Nonane-2-Carboxylate Hydrochloride(WXC00548);ALLYL 2,7-DIAZASPIRO[3.5]NONANE-2-CARBOXYLATE HCL;Allyl 2,7-Diazaspiro[3.5]Nonane-2-Carboxylate Hydrochloride;2,7-Diazaspiro[3.5]nonane-2-carboxylic acid, 2-propen-1-yl ester, hydrochloride (1:1)
CAS No.2007921-06-2

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACWNML252 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACWNML252 route product structure diagram
    ACWNML2522007921-06-2
Inquiry

2. ACWNML252 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACWNML252 route product structure diagram
    ACWNML2522007921-06-2
Inquiry

3. ACWNML252 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACWNML252 route product structure diagram
    ACWNML2522007921-06-2
Inquiry

Comments (0)